Annual EBITDA
$52.58 M
-$19.01 M-26.56%
31 March 2024
Summary:
Taro Pharmaceutical Industries annual earnings before interest, taxes, depreciation & amortization is currently $52.58 million, with the most recent change of -$19.01 million (-26.56%) on 31 March 2024. During the last 3 years, it has risen by +$418.61 million (+114.36%).TARO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$17.01 M
-$6.25 M-26.88%
31 March 2024
Summary:
Taro Pharmaceutical Industries quarterly earnings before interest, taxes, depreciation & amortization is currently $17.01 million, with the most recent change of -$6.25 million (-26.88%) on 31 March 2024. Over the past year, it has increased by +$4.66 million (+37.75%).TARO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$52.58 M
-$24.83 M-32.07%
31 March 2024
Summary:
Taro Pharmaceutical Industries TTM earnings before interest, taxes, depreciation & amortization is currently $52.58 million, with the most recent change of -$24.83 million (-32.07%) on 31 March 2024. Over the past year, it has dropped by -$10.18 million (-16.21%).TARO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.6% | +37.8% | -16.2% |
| 3 y3 years | +114.4% | -47.4% | +114.3% |
| 5 y5 years | -86.0% | -75.0% | -85.7% |
TARO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -91.9% | -92.1% | -92.3% |
Taro Pharmaceutical Industries EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | $52.58 M(-26.6%) | $17.01 M(-26.9%) | $52.58 M(-32.1%) |
| Dec 2023 | - | $23.26 M(+88.4%) | $77.41 M(+23.3%) |
| Sept 2023 | - | $12.35 M(<-9900.0%) | $62.75 M(+24.0%) |
| June 2023 | - | -$30.00 K(-100.1%) | $50.61 M(-29.3%) |
| Mar 2023 | $71.59 M(-32.1%) | $41.83 M(+386.1%) | $71.59 M(+481.6%) |
| Dec 2022 | - | $8.61 M(+4181.1%) | $12.31 M(-73.9%) |
| Sept 2022 | - | $201.00 K(-99.0%) | $47.15 M(-40.5%) |
| June 2022 | - | $20.95 M(-220.1%) | $79.26 M(-24.8%) |
| Mar 2022 | $105.43 M(-128.8%) | -$17.45 M(-140.2%) | $105.43 M(-128.7%) |
| Dec 2021 | - | $43.45 M(+34.4%) | -$367.53 M(-0.3%) |
| Sept 2021 | - | $32.31 M(-31.4%) | -$368.69 M(+4.1%) |
| June 2021 | - | $47.12 M(-109.6%) | -$354.25 M(-3.2%) |
| Mar 2021 | -$366.03 M(-214.3%) | -$490.40 M(-1259.8%) | -$366.03 M(-253.1%) |
| Dec 2020 | - | $42.28 M(-9.6%) | $239.09 M(-8.2%) |
| Sept 2020 | - | $46.75 M(+32.3%) | $260.45 M(-7.6%) |
| June 2020 | - | $35.34 M(-69.2%) | $281.85 M(-12.0%) |
| Mar 2020 | $320.14 M(-14.8%) | $114.72 M(+80.2%) | $320.14 M(-7.6%) |
| Dec 2019 | - | $63.65 M(-6.6%) | $346.58 M(-5.5%) |
| Sept 2019 | - | $68.14 M(-7.5%) | $366.79 M(-4.0%) |
| June 2019 | - | $73.63 M(-47.8%) | $381.89 M(+1.6%) |
| Mar 2019 | $375.71 M(+21.5%) | $141.16 M(+68.3%) | $375.71 M(+24.6%) |
| Dec 2018 | - | $83.86 M(+0.7%) | $301.65 M(+5.6%) |
| Sept 2018 | - | $83.24 M(+23.4%) | $285.65 M(-3.2%) |
| June 2018 | - | $67.45 M(+0.5%) | $295.21 M(-4.5%) |
| Mar 2018 | $309.17 M(-46.3%) | $67.10 M(-1.1%) | $309.17 M(-21.4%) |
| Dec 2017 | - | $67.86 M(-26.9%) | $393.55 M(-14.1%) |
| Sept 2017 | - | $92.80 M(+14.0%) | $458.40 M(-10.3%) |
| June 2017 | - | $81.41 M(-46.3%) | $510.86 M(-11.3%) |
| Mar 2017 | $575.76 M(-11.7%) | $151.48 M(+14.2%) | $575.76 M(-8.8%) |
| Dec 2016 | - | $132.70 M(-8.6%) | $631.39 M(-6.5%) |
| Sept 2016 | - | $145.26 M(-0.7%) | $675.58 M(+2.3%) |
| June 2016 | - | $146.31 M(-29.4%) | $660.17 M(+1.2%) |
| Mar 2016 | $652.14 M(+9.0%) | $207.12 M(+17.1%) | $652.14 M(-1.4%) |
| Dec 2015 | - | $176.89 M(+36.2%) | $661.61 M(+2.1%) |
| Sept 2015 | - | $129.85 M(-6.1%) | $647.99 M(-5.4%) |
| June 2015 | - | $138.28 M(-36.2%) | $684.73 M(+14.4%) |
| Mar 2015 | $598.41 M(+29.5%) | $216.58 M(+32.7%) | $598.41 M(+19.7%) |
| Dec 2014 | - | $163.27 M(-2.0%) | $500.11 M(+5.0%) |
| Sept 2014 | - | $166.60 M(+220.6%) | $476.34 M(+9.2%) |
| June 2014 | - | $51.96 M(-56.1%) | $436.16 M(-5.6%) |
| Mar 2014 | $461.99 M(+29.7%) | $118.28 M(-15.2%) | $461.99 M(+12.8%) |
| Dec 2013 | - | $139.50 M(+10.3%) | $409.62 M(+7.3%) |
| Sept 2013 | - | $126.42 M(+62.5%) | $381.91 M(+9.0%) |
| June 2013 | - | $77.78 M(+18.0%) | $350.39 M(-1.9%) |
| Mar 2013 | $356.14 M(+408.1%) | $65.91 M(-41.0%) | $357.21 M(-1.3%) |
| Dec 2012 | - | $111.79 M(+17.8%) | $362.02 M(+9.7%) |
| Sept 2012 | - | $94.91 M(+12.2%) | $330.05 M(+3.8%) |
| June 2012 | - | $84.60 M(+19.6%) | $318.03 M(+17.5%) |
| Mar 2012 | $70.09 M(-69.7%) | $70.73 M(-11.4%) | $270.66 M(+13.8%) |
| Dec 2011 | $231.66 M(+132.9%) | $79.81 M(-3.7%) | $237.88 M(+32.1%) |
| Sept 2011 | - | $82.89 M(+122.6%) | $180.06 M(+44.3%) |
| June 2011 | - | $37.24 M(-1.9%) | $124.78 M(+7.5%) |
| Mar 2011 | - | $37.94 M(+72.5%) | $116.05 M(+18.9%) |
| Dec 2010 | $99.46 M(+21.7%) | $21.99 M(-20.4%) | $97.63 M(-7.0%) |
| Sept 2010 | - | $27.61 M(-3.1%) | $105.01 M(+11.2%) |
| June 2010 | - | $28.50 M(+45.9%) | $94.44 M(+16.7%) |
| Mar 2010 | - | $19.53 M(-33.5%) | $80.94 M(+3.6%) |
| Dec 2009 | $81.70 M(+23.7%) | $29.37 M(+72.3%) | $78.14 M(+71.6%) |
| Sept 2009 | - | $17.04 M(+13.6%) | $45.55 M(-6.8%) |
| June 2009 | - | $15.00 M(-10.4%) | $48.85 M(-4.7%) |
| Mar 2009 | - | $16.73 M(-618.4%) | $51.23 M(+48.5%) |
| Dec 2008 | $66.04 M(-23.2%) | -$3.23 M(-115.9%) | $34.50 M(-8.6%) |
| Sept 2008 | - | $20.34 M(+17.1%) | $37.73 M(+117.1%) |
| June 2008 | - | $17.38 M(-391.4%) | $17.38 M(+29.8%) |
| Dec 2007 | $85.98 M(-290.0%) | - | - |
| Dec 2006 | -$45.24 M(-226.5%) | - | - |
| Dec 2005 | $35.76 M(+87.2%) | -$5.96 M(-259.1%) | $13.39 M(-43.1%) |
| Sept 2005 | - | $3.75 M(-55.0%) | $23.53 M(+6.0%) |
| June 2005 | - | $8.33 M(+14.5%) | $22.19 M(-694.0%) |
| Mar 2005 | - | $7.28 M(+74.3%) | -$3.74 M(+622.6%) |
| Dec 2004 | $19.11 M | $4.17 M(+73.3%) | -$517.00 K(-103.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2004 | - | $2.41 M(-113.7%) | $14.21 M(-54.8%) |
| June 2004 | - | -$17.59 M(-267.7%) | $31.46 M(-53.1%) |
| Mar 2004 | - | $10.49 M(-44.5%) | $67.06 M(-10.2%) |
| Dec 2003 | $89.10 M(+44.5%) | $18.90 M(-3.9%) | $74.69 M(+4.7%) |
| Sept 2003 | - | $19.66 M(+9.2%) | $71.31 M(+8.5%) |
| June 2003 | - | $18.01 M(-0.6%) | $65.73 M(+10.2%) |
| Mar 2003 | - | $18.12 M(+16.7%) | $59.63 M(+12.0%) |
| Dec 2002 | $61.66 M(+56.0%) | $15.53 M(+10.3%) | $53.26 M(+8.8%) |
| Sept 2002 | - | $14.07 M(+18.1%) | $48.93 M(+9.2%) |
| June 2002 | - | $11.91 M(+1.4%) | $44.79 M(+11.1%) |
| Mar 2002 | - | $11.74 M(+4.9%) | $40.33 M(+23.0%) |
| Dec 2001 | $39.53 M(+41.4%) | $11.20 M(+12.6%) | $32.77 M(+0.5%) |
| Sept 2001 | - | $9.94 M(+33.5%) | $32.61 M(+20.0%) |
| June 2001 | - | $7.45 M(+77.7%) | $27.19 M(+18.2%) |
| Mar 2001 | - | $4.19 M(-62.0%) | $23.00 M(+4.7%) |
| Dec 2000 | $27.95 M(+83.6%) | $11.04 M(+144.5%) | $21.96 M(+65.9%) |
| Sept 2000 | - | $4.51 M(+38.4%) | $13.23 M(+10.4%) |
| June 2000 | - | $3.26 M(+3.3%) | $11.99 M(+4.0%) |
| Mar 2000 | - | $3.15 M(+36.8%) | $11.53 M(+8.7%) |
| Dec 1999 | $15.22 M(+44.6%) | $2.31 M(-29.4%) | $10.61 M(-132.9%) |
| Sept 1999 | - | $3.27 M(+16.6%) | -$32.27 M(+76.0%) |
| June 1999 | - | $2.80 M(+25.6%) | -$18.34 M(+278.7%) |
| Mar 1999 | - | $2.23 M(-105.5%) | -$4.84 M(-25.2%) |
| Dec 1998 | $10.53 M(+42.8%) | -$40.58 M(-335.9%) | -$6.47 M(-118.5%) |
| Sept 1998 | - | $17.20 M(+5.5%) | $34.97 M(+78.7%) |
| June 1998 | - | $16.30 M(+2616.7%) | $19.57 M(+347.7%) |
| Mar 1998 | - | $600.00 K(-31.1%) | $4.37 M(0.0%) |
| Dec 1997 | $7.37 M(+2.4%) | $871.00 K(-51.6%) | $4.37 M(-7.0%) |
| Sept 1997 | - | $1.80 M(+63.6%) | $4.70 M(+9.3%) |
| June 1997 | - | $1.10 M(+83.3%) | $4.30 M(-8.5%) |
| Mar 1997 | - | $600.00 K(-50.0%) | $4.70 M(-2.1%) |
| Dec 1996 | $7.20 M(+1.4%) | $1.20 M(-14.3%) | $4.80 M(-117.0%) |
| Sept 1996 | - | $1.40 M(-6.7%) | -$28.20 M(+67.9%) |
| June 1996 | - | $1.50 M(+114.3%) | -$16.80 M(+223.1%) |
| Mar 1996 | - | $700.00 K(-102.2%) | -$5.20 M(-198.1%) |
| Dec 1995 | $7.10 M(-16.5%) | -$31.80 M(-348.4%) | $5.30 M(-65.1%) |
| Sept 1995 | - | $12.80 M(-2.3%) | $15.20 M(+23.6%) |
| June 1995 | - | $13.10 M(+17.0%) | $12.30 M(+33.7%) |
| Mar 1995 | - | $11.20 M(-151.1%) | $9.20 M(+29.6%) |
| Dec 1994 | $8.50 M(+254.2%) | -$21.90 M(-321.2%) | $7.10 M(-27.6%) |
| Sept 1994 | - | $9.90 M(-1.0%) | $9.80 M(+55.6%) |
| June 1994 | - | $10.00 M(+9.9%) | $6.30 M(+61.5%) |
| Mar 1994 | - | $9.10 M(-147.4%) | $3.90 M(+178.6%) |
| Dec 1993 | $2.40 M(-7.7%) | -$19.20 M(-400.0%) | $1.40 M(-93.2%) |
| Sept 1993 | - | $6.40 M(-15.8%) | $20.50 M(+37.6%) |
| June 1993 | - | $7.60 M(+15.2%) | $14.90 M(+91.0%) |
| Mar 1993 | - | $6.60 M(-6700.0%) | $7.80 M(+290.0%) |
| Dec 1992 | $2.60 M(-23.5%) | -$100.00 K(-112.5%) | $2.00 M(-39.4%) |
| Sept 1992 | - | $800.00 K(+60.0%) | $3.30 M(0.0%) |
| June 1992 | - | $500.00 K(-37.5%) | $3.30 M(-2.9%) |
| Mar 1992 | - | $800.00 K(-33.3%) | $3.40 M(+9.7%) |
| Dec 1991 | $3.40 M(+161.5%) | $1.20 M(+50.0%) | $3.10 M(-146.3%) |
| Sept 1991 | - | $800.00 K(+33.3%) | -$6.70 M(+59.5%) |
| June 1991 | - | $600.00 K(+20.0%) | -$4.20 M(+180.0%) |
| Mar 1991 | - | $500.00 K(-105.8%) | -$1.50 M(-31.8%) |
| Dec 1990 | $1.30 M(+18.2%) | -$8.60 M(-360.6%) | -$2.20 M(+29.4%) |
| Sept 1990 | - | $3.30 M(0.0%) | -$1.70 M(+6.3%) |
| June 1990 | - | $3.30 M(-1750.0%) | -$1.60 M(-27.3%) |
| Mar 1990 | - | -$200.00 K(-97.5%) | -$2.20 M(-466.7%) |
| Dec 1989 | $1.10 M(+83.3%) | -$8.10 M(-338.2%) | $600.00 K(-62.5%) |
| Sept 1989 | - | $3.40 M(+25.9%) | $1.60 M(+433.3%) |
| June 1989 | - | $2.70 M(+3.8%) | $300.00 K(+50.0%) |
| Mar 1989 | - | $2.60 M(-136.6%) | $200.00 K(>+9900.0%) |
| Dec 1988 | $600.00 K(+100.0%) | -$7.10 M(-438.1%) | $0.00(-100.0%) |
| Sept 1988 | - | $2.10 M(-19.2%) | $1.40 M(+7.7%) |
| June 1988 | - | $2.60 M(+8.3%) | $1.30 M(+85.7%) |
| Mar 1988 | - | $2.40 M(-142.1%) | $700.00 K(+133.3%) |
| Dec 1987 | $300.00 K | -$5.70 M(-385.0%) | $300.00 K(-95.0%) |
| Sept 1987 | - | $2.00 M(0.0%) | $6.00 M(+50.0%) |
| June 1987 | - | $2.00 M(0.0%) | $4.00 M(+100.0%) |
| Mar 1987 | - | $2.00 M | $2.00 M |
FAQ
- What is Taro Pharmaceutical Industries annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries annual EBITDA year-on-year change?
- What is Taro Pharmaceutical Industries quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries quarterly EBITDA year-on-year change?
- What is Taro Pharmaceutical Industries TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries TTM EBITDA year-on-year change?
What is Taro Pharmaceutical Industries annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of TARO is $52.58 M
What is the all time high annual EBITDA for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high annual earnings before interest, taxes, depreciation & amortization is $652.14 M
What is Taro Pharmaceutical Industries annual EBITDA year-on-year change?
Over the past year, TARO annual earnings before interest, taxes, depreciation & amortization has changed by -$19.01 M (-26.56%)
What is Taro Pharmaceutical Industries quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of TARO is $17.01 M
What is the all time high quarterly EBITDA for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high quarterly earnings before interest, taxes, depreciation & amortization is $216.58 M
What is Taro Pharmaceutical Industries quarterly EBITDA year-on-year change?
Over the past year, TARO quarterly earnings before interest, taxes, depreciation & amortization has changed by +$4.66 M (+37.75%)
What is Taro Pharmaceutical Industries TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of TARO is $52.58 M
What is the all time high TTM EBITDA for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high TTM earnings before interest, taxes, depreciation & amortization is $684.73 M
What is Taro Pharmaceutical Industries TTM EBITDA year-on-year change?
Over the past year, TARO TTM earnings before interest, taxes, depreciation & amortization has changed by -$10.18 M (-16.21%)